Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharmatek Gains DEA Approval for Controlled Substances | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pharmatek Gains DEA Approval for Controlled Substances

Pharmatek Laboratories, Inc. has successfully met Drug Enforcement Agency (DEA) requirements for the development and manufacture of Schedule IV and V controlled substances.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharmatek Laboratories, Inc. has successfully met Drug Enforcement Agency (DEA) requirements for the development and manufacture of Schedule IV and V controlled substances.

“Based on the needs of our clients, Pharmatek has put significant systems in place for the handling, inventory, development and manufacture of controlled substances,” said Kevin Rosenthal, director of manufacturing. “Being registered by the DEA validates our facility design, security systems, and procedures for manufacturing, handling, storage and disposal meet the stringent requirements of the DEA.”

“Our goal is to continue to strive to meet the needs of our existing and prospective clients by adding to our capabilities in pharmaceutical chemistry development and manufacturing,” said Timothy Scott, president at Pharmatek. “As a client-centric organization, our success is predicated on our ability to serve our clients. We are happy to bring this additional capability to Pharmatek in order to serve that purpose.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics